UK will pay for Roche breast cancer drug at center of price row
LONDON (Reuters) - A Roche breast cancer drug at the center of a prolonged pricing row in Britain will now be paid for routinely, following a discount deal between the company and the National Health Service, the country's cost watchdog said on Thursday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Health | National Health Service (NHS) | UK Health